Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

You may be eligible if

• Prior/Concurrent Therapy Criteria
• 1. Patients must be initiating a new treatment regimen for pancreatic cancer at the time of their initiation in the study
• 2. Patients must have cytologic or histologic confirmation of pancreatic cancer
• 3. Patients must have measurable radiographic evidence of metastatic disease
• 4. Patients must be ≥18 years of age
• 5. Patients must have an ECOG Performance Status 0-2.
• 6. Patients must have adequate organ function for delivery of chemotherapy as evidenced by the following: Hgb ≥8 g/dL, platelets ≥ 75
• 7. Patients must not have renal dysfunction that would prevent administration of IV contrast for radiographic assessment.
• Regulatory Criteria
• 8. Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines.
• 9. Patients of all races, genders, \& ethnicities are eligible.